Break Up the Insulin Racket
Too many Americans with diabetes can’t afford their medication.
Hasnain says:
"What makes this so worrisome is that the big three have simultaneously hiked their prices. From 2010 to 2015, the price of Lantus (made by Sanofi) went up by 168 percent; the price of Levemir (made by Novo Nordisk) rose by 169 percent; and the price of Humulin R U-500 (made by Eli Lilly) soared by 325 percent."
Posted on 2016-02-24T05:41:46+0000